Skip to main content
. 2021 Mar 26;13(7):1531. doi: 10.3390/cancers13071531

Figure 5.

Figure 5

Scatterplots showing TP53 transcript abundance by TP53 mutation status in breast cancer cohorts. (a–i) TP53 transcript levels in New Zealand breast cancer cohort, quantitated by long amplicon ddPCR. (a) LRG_321t1 encoding FL/∆40p53α, (b) LRG_321t2 encoding FL/∆40p53α, (c) LRG_321t3 encoding FL/∆40p53β, (d) LRG_321t4 encoding FL/∆40p53γ, (e) LRG_321t5 encoding ∆133p53α, (f) LRG_321t6 encoding ∆133p53β, (g) LRG_321t7 encoding ∆133p53γ, (h) LRG_321t8 encoding ∆40p53α, and (i) t8β encoding ∆40p53β, in each tumor. (j,k) TP53 transcript levels from the TCGA BRCA cohort, quantitated by RNA-seq, (j) uc002gij.2, encoding FL/∆40p53α, (k) uc010cni.1, encoding FL/∆40p53β. Bar represents the median, with symbols representing individual tumor samples.